{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-247410","form_type":"8-K","ticker":"VRDN","cik":"0001590750","company_name":"Viridian Therapeutics, Inc.\\DE","filed_at":"2025-10-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.848732+00:00","generated_at":"2026-05-17T02:30:32.401308+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Viridian Therapeutics priced 11.4M-share offering at $22/sh for ~$251M gross proceeds","bullets":["Offering of 11,425,000 shares at $22.00/share; underwriters have 30-day option for up to 1,713,750 additional shares.","Gross proceeds of ~$251.35M before underwriting discounts and expenses; closing expected October 23, 2025.","Net proceeds combined with existing cash, $70M Kissei upfront (Q4 2025), $55M DRI payment, $115M potential DRI milestones, and $30M term loan to fund operations.","Company assumes revenue from veligrotug and VRDN-003 if approved on anticipated timelines to extend cash runway."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-247410","json":"https://secwatch.observer/filing/0001193125-25-247410.json","markdown":"https://secwatch.observer/filing/0001193125-25-247410.md","text":"https://secwatch.observer/filing/0001193125-25-247410.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590750/000119312525247410/0001193125-25-247410-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590750/000119312525247410/d27166d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:30:32.401308+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}